Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT

Journal of Clinical Gastroenterology

Volumn 42, Issue 7, 2008, Pages 820-826

  Wang, Chia C ^a   Lim, Lei Y ^a   Deubner, Heike ^a   Tapia, Kenneth ^a   Lau, Agnes W Y ^a   Manansala, Jaime ^a   Krows, Meighan ^a   Shuhart, Margaret C ^a   Kowdley, Kris V ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hepatitis B; Immunotolerant; Liver biopsy; Normal ALT

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL LABORATORY; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; LIVER BIOPSY; LIVER FIBROSIS; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; BLOOD; DISEASE COURSE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE TOLERANCE; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE;

EID: 53749084411     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318156feef     Document Type: Article

References (18)

1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45: 507-539.
2. Keeffe EB, Dieterich DT, Han SH, et al. A Treatment algorithm for the management of chronic hepatitis B infection in the United States: an update. Gastroenterology. 2006;4:936-962.
3. Piton A, Poynard T, Imbert-Bismut F, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology. 1998;27:1213-1219.
4. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1-10.
5. Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328:983.
6. Bacon BR. Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology. 2002;36(5 suppl 1): S179-S184.
7. Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37:1286-1292.
8. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The Evidence REPORT. National Institutes of Health. Obes Res. 1998;6 (suppl 2):51S-209S.
9. Loeb KR, Jerome KR, Goddard J, et al. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology. 2000;32: 626-629.
10. Limaye AP, Huang ML, Leisenring W, et al. Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. J Infect Dis. 2001;183:377-382.
11. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19:1409-1417.
12. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005;172:899-905.
13. Brunt EM, Neuschwander-Tetri BA, Oliver D, et al. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol. 2004;35:1070-1082.
14. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113-121.
15. Zeuzem S, Diago M, Gane E, et al. Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology. 2004;127: 1724-1732.
16. Prati D, Shiffman ML, Diago M, et al. Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C. J Hepatol. 2006;44:679-685.
17. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215-229.
18. Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346:1682-1683.